Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the origina...

Full description

Bibliographic Details
Main Authors:	Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-03-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/corrigendum-effects-of-switching-from-olanzapine-to-aripiprazole--peer-reviewed-article-NDT

id	doaj-32a0b5cd2d9e4624bc44e362f32dc01b
record_format	Article
spelling	doaj-32a0b5cd2d9e4624bc44e362f32dc01b2020-11-25T00:40:36ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212015-03-012015default86386421065Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]Wani RADar MAChandel RKRather YHHaq IHussain AMalla AA Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the original paper http://www.dovepress.com/corrigendum-effects-of-switching-from-olanzapine-to-aripiprazole--peer-reviewed-article-NDT
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA
spellingShingle	Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum] Neuropsychiatric Disease and Treatment
author_facet	Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA
author_sort	Wani RA
title	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_short	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_full	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_fullStr	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_full_unstemmed	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_sort	effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [corrigendum]
publisher	Dove Medical Press
series	Neuropsychiatric Disease and Treatment
issn	1178-2021
publishDate	2015-03-01
description	Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the original paper
url	http://www.dovepress.com/corrigendum-effects-of-switching-from-olanzapine-to-aripiprazole--peer-reviewed-article-NDT
work_keys_str_mv	AT wanira effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT darma effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT chandelrk effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT ratheryh effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT haqi effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT hussaina effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT mallaaa effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum
_version_	1725289175374102528

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Similar Items